Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 16;12(5):931-941.
doi: 10.12998/wjcc.v12.i5.931.

Value of glucose transport protein 1 expression in detecting lymph node metastasis in patients with colorectal cancer

Hongsik Kim  1 , Song-Yi Choi  2 , Tae-Young Heo  3 , Kyeong-Rok Kim  3 , Jisun Lee  4 , Min Young Yoo  5 , Taek-Gu Lee  6 , Joung-Ho Han  7
Affiliations

Value of glucose transport protein 1 expression in detecting lymph node metastasis in patients with colorectal cancer

Hongsik Kim et al. World J Clin Cases. .

Abstract

Background: There are limited data on the use of glucose transport protein 1 (GLUT-1) expression as a biomarker for predicting lymph node metastasis in patients with colorectal cancer. GLUT-1 and GLUT-3, hexokinase (HK)-II, and hypoxia-induced factor (HIF)-1 expressions may be useful biomarkers for detecting primary tumors and lymph node metastasis when combined with fluorodeoxyglucose (FDG) uptake on positron emission tomography/computed tomography (PET/CT).

Aim: To evaluate GLUT-1, GLUT-3, HK-II, and HIF-1 expressions as biomarkers for detecting primary tumors and lymph node metastasis with 18F-FDG-PET/CT.

Methods: This retrospective study included 169 patients with colorectal cancer who underwent colectomy and preoperative 18F-FDG-PET/CT at Chungbuk National University Hospital between January 2009 and May 2012. Two tissue cores from the central and peripheral areas of the tumors were obtained and were examined by a dedicated pathologist, and the expressions of GLUT-1, GLUT-3, HK-II, and HIF-1 were determined using immunohistochemical staining. We analyzed the correlations among their expressions, various clinicopathological factors, and the maximum standardized uptake value (SUVmax) of PET/CT.

Results: GLUT-1 was found at the center or periphery of the tumors in 109 (64.5%) of the 169 patients. GLUT-1 positivity was significantly correlated with the SUVmax of the primary tumor and lymph nodes, regardless of the biopsy site (tumor center, P < 0.001 and P = 0.012; tumor periphery, P = 0.030 and P = 0.010, respectively). GLUT-1 positivity and negativity were associated with higher and lower sensitivities of PET/CT, respectively, for the detection of lymph node metastasis, regardless of the biopsy site. GLUT3, HK-II, and HIF-1 expressions were not significantly correlated with the SUVmax of the primary tumor and lymph nodes.

Conclusion: GLUT-1 expression was significantly correlated with the SUVmax of 18F-FDG-PET/CT for primary tumors and lymph nodes. Clinicians should consider GLUT-1 expression in preoperative endoscopic biopsy in interpreting PET/CT findings.

Keywords: 18F-FDG-PET-CT; Biomarker; Colorectal neoplasms; Glucose transporter type 1; Lymph node.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors have no conflict of interest to declare regarding the publication of this work.

Figures

Figure 1
Figure 1
Immunohistochemical staining for glucose transport protein 1 in colorectal cancer. Glucose transport protein 1 expression was demonstrated as cytoplasmic or membranous staining. A-D: The score was assessed according to the intensity [0 = negative (A), 1 = weak (B), 2 = moderate (C), 3 = strong (D); × 100]. A score of 2 or higher was considered as positive.
Figure 2
Figure 2
Immunohistochemical staining for glucose transport protein 3, hexokinase-II, and hypoxia-inducible factor-1 in colorectal cancer. Glucose transport protein 3 (GLUT-3) and hexokinase-II expressions were demonstrated as cytoplasmic or membranous staining. A: GLUT-3 negative; B: GLUT-3 positive; C: Hexokinase-II negative; D: Hexokinase-II positive; E and F: Hypoxia-inducible factor-1 (HIF-1) expression was demonstrated as nuclear staining (E: HIF-1 negative, F: HIF-1 positive).
See this image and copyright information in PMC

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
    1. Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, Brown G, McLeod R, Kennedy E. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212–2223. - PubMed
    1. Dighe S, Purkayastha S, Swift I, Tekkis PP, Darzi A, A'Hern R, Brown G. Diagnostic precision of CT in local staging of colon cancers: a meta-analysis. Clin Radiol. 2010;65:708–719. - PubMed
    1. Nasseri Y, Langenfeld SJ. Imaging for Colorectal Cancer. Surg Clin North Am. 2017;97:503–513. - PubMed
    1. Park IJ, Kim HC, Yu CS, Ryu MH, Chang HM, Kim JH, Ryu JS, Yeo JS, Kim JC. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol. 2006;32:941–947. - PubMed